Literature DB >> 7913660

Thyroid medullary carcinoma with thyroglobulin immunoreactivity in sporadic multiple endocrine neoplasia type 2-B.

C S Kovacs1, R M Masé, K Kovacs, G K Nguyen, C L Chik.   

Abstract

BACKGROUND: Thyroid carcinomas historically have been divided into two groups according to their presumedly separate embryonic origins: those of neuroectodermal derivation (parafollicular or medullary carcinoma [MCT]) and those of foregut endodermal origin (follicular and papillary carcinomas). The validity of this concept has been questioned by the recognition that some MCT may show immunocytochemical and ultrastructural evidence of follicular components, and display features of follicular function (e.g., organification of iodine, immunoreactivity for thyroglobulin).
METHODS: A 14-year-old boy presented with the physical features of multiple endocrine neoplasia type 2-B (MEN 2B) and a thyroid mass. His thyroid lesion was studied by light microscopy; electron microscopy; immunohistochemistry using antisera to calcitonin, thyroglobulin, and other peptides; and in situ hybridization.
RESULTS: The tumor was identified as an MCT by light microscopy. It stained positively with calcitonin, thyroglobulin, chromogranin, neuron-specific enolase, and serotonin. At the ultrastructural level, the tumor cells contained numerous neurosecretory granules and showed evidence of follicular differentiation (luminal microvilli, follicle formation, and tight junctions), suggesting a dual neuroendocrine and follicular differentiation.
CONCLUSIONS: The morphologic findings suggest that a small number of MCTs arise from a common stem cell (possibly the ultimobranchial body) that may give rise to both MCT and follicular carcinoma. This patient and patients in similar cases documented in the literature challenge the classic concept of separate pathways of embryogenesis for these two cell types.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913660     DOI: 10.1002/1097-0142(19940801)74:3<928::aid-cncr2820740321>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Combined "Mixed Medullary-Follicular" and "Papillary" Carcinoma of the Thyroid with Lymph Node Metastasis.

Authors:  Michio Shimizu; Mitsuyoshi Hirokawa; Virginia A. LiVolsi; Yuji Mizukami; Tanekazu Harada; Tomoo Itoh; Toshiaki Manabe
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

2.  Conjunction of follicular, papillary and medullary thyroid carcinomas in a young woman.

Authors:  M E Sayegh; N R Griffin
Journal:  J R Soc Med       Date:  1999-01       Impact factor: 5.344

3.  Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components.

Authors:  M Volante; M Papotti; J Roth; P Saremaslani; E J Speel; R V Lloyd; J A Carney; P U Heitz; G Bussolati; P Komminoth
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment.

Authors:  F Y Miasaki; A Vivaldi; R Ciampi; L Agate; P Collecchi; A Capodanno; A Pinchera; R Elisei
Journal:  J Endocrinol Invest       Date:  2008-08       Impact factor: 4.256

Review 5.  On the Origin of Cells and Derivation of Thyroid Cancer: C Cell Story Revisited.

Authors:  Mikael Nilsson; Dillwyn Williams
Journal:  Eur Thyroid J       Date:  2016-06-24

6.  The Pathology of Medullary Carcinoma of the Thyroid: Review of the Literature and Personal Experience on 62 Cases.

Authors:  Mauro Papotti; Daniela Sambataro; Carla Pecchioni; Gianni Bussolati
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

Review 7.  Goblet cell carcinoids and other mixed neuroendocrine/nonneuroendocrine neoplasms.

Authors:  Marco Volante; Luisella Righi; Sofia Asioli; Gianni Bussolati; Mauro Papotti
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.